Multicenter Trial for Treatment of Acute Lymphocytic Leukemia in Adults (Pilot Study 06/99)
Phase 4
15 Years
65 Years
15 Years
65 Years
Not Enrolling
Both
Adult Acute Lymphocytic Leukemia
Both
Adult Acute Lymphocytic Leukemia
Trial Information
Multicenter Trial for Treatment of Acute Lymphocytic Leukemia in Adults (Pilot Study 06/99)
Inclusion Criteria:
- Acute lymphoblastic leukemia (pro-B, common, pre-B, early T, T)
- Age 15-65 yrs (*55-65 years if biologically younger according to general condition)
Exclusion Criteria:
- Severe comorbidity
- Cytostatic pre-treatment
- Pregnancy
- Missing written informed consent
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Remission rate,Remission duration,Disease free survival,Overall survival
Principal Investigator
Dieter Hoelzer, MD,PhD
Investigator Role:
Study Chair
Investigator Affiliation:
University Hospital Frankfurt, Medical Dept. II
Authority:
Germany: Federal Institute for Drugs and Medical Devices
Study ID:
GMALL10
NCT ID:
NCT00199056
Start Date:
October 1999
Completion Date:
Related Keywords:
- Adult Acute Lymphocytic Leukemia
- ALL
- Treatment
- De Novo
- Adult
- Leukemia
- Leukemia, Lymphoid
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
Name | Location |
|---|
